AmplifyBio is adding manufacturing services, starting with cell therapy and plasmids, to its growing capabilities to support the safe development of advanced therapies.

AmplifyBio announces $50M in debt financing to accelerate the expansion of its service offering, supporting the rapid, safe development of next-generation therapeutics

World Stem Cell Summit and Phacilitate Leaders World to bring FOUR Meetings Together to Create Collaboration Needed to Deliver Global Cell and Gene Therapies!

ISCT confirmed as strategic partner for Phacilitate's trade mission to Asia, June 2018

Phacilitate announces launch of digital publishing platform